SOAT1 and hepatocellular carcinoma: These RTKs are known to activate multiple downstream signaling cascades, including PI3K/AKT, RAS/MAPK, and JAK/STAT, all of which are frequently dysregulated in HCC and contribute to resistance to conventional therapies [20].